On July 30, 2018, GNA Biosolutions was named the winner of the American Association of Clinical Chemistry’s (AACC) first-ever 'Disruptive Technology Award'.
GNA presented data on the company’s proprietary Pulse Controlled Amplification (PCA) technology during a featured session at the 70th AACC Annual Scientific Meeting & Clinical Lab Expo. The AACC Disruptive Technology Award recognizes innovative testing solutions that improve patient care through diagnostic performance or access to high-quality testing.
Congratulation to the GNA-Team!